Blood count, metabolic parameters (glucose, cholesterol, triglyceride, HbA1c, leptin, insulin), immune globuline levels (IgG, IgA, IgM), tumor markers (CEA, CA15.3), homocystein, TNF‐alpha, c‐peptide, IGF‐1, IGF‐1BP, sex hormone‐binding globulin, and hormone levels (FSH, LH, progesterone, testosterone, E2). The gene discussed is IGF1; the disease is neoplasm.